R2 Researcher at Genetics of Complex Inflammatory Diseases group

Date limit
Fundación Pública Andaluza Progreso y Salud (FPS)

Fundación Pública Andaluza Progreso y Salud (FPS) groups are looking for R2 researchers who can apply for competitive HR grant CONVOCATORIA DE INCORPORACIÓN DE INVESTIGADORES POSDOCTORALES A GRUPOS DE LOS CENTROS SANITARIOS Y DE INVESTIGACIÓN DEL SSPA 2024 of the Consejería de Salud y Consumo:

Eligibility requirements (candidates should) for Junior postdoctoral contract:

  • Have the status of a job seeker or, at the very least, hold an employment improvement card issued by the competent Public Employment Service as of the date of submission of the application, which must be maintained until the date of formalization of the employment contract.
  • Hold a PhD degree in the field of Health Sciences and Technologies of less or equal to five years. In calculating the five years, interruptions due to justified reasons (maternity or paternity, adoption, temporary incapacity due to illness or accident, temporary incapacity during pregnancy, or caring for dependents) will be excluded, provided they are within the five years preceding the application.
  • Have a research trajectory aligned with that of the host group, which will be evidenced in the declaration of the application and through the submission of a curriculum vitae.
  • Be the author of at least two biomedical research publications, indexed in the Journal Citation Report (JCR), being the lead person as first author, last author or corresponding author, in at least one of them.

More information 

Information on host group

Group: Genetics of Complex Inflammatory Diseases

Principal Investigator of the Group: Concepción Marañón Lizana. Pfizer - University of Granada - Junta de Andalucía Centre for Genomics and Oncological Research (GENYO).

Research line in which the candidate will work:

a) IFN-directed drugs as a therapeutic approach for systemic autoimmune diseases

Since plasmacytoid dendritic cells (pDC) are key players in the control of autoimmune responses through the production of high amounts of IFN, we propose a multidisciplinary pDC-based strategy for the discovery of novel strategic approaches for the management of prototypic IFN-mediated diseases, namely psoriasis (PSO), systemic lupus erythematosus (SLE) and Sjögren syndrome (SjS). Our approach integrates computational methods, in vitro screening and in vivo testing, in the search of both new repurposing strategies and the discovery of new active molecules. This project proposes novel and integrative strategies allowing the advance in the development of new therapeutic options of SADs patients.

Profile of the desired candidate:

Application submission: from 24th May to 7th June 2024